ObjectiveTo investigate the effects of Tangmaikang on oxidative and carbonyl stress in streptozocin-induced diabetic rat kidneys,and to also explore their reno- protecting mechanisms in diabetic rats.MethodsRats were randomly divided into three sub-groups:normal control (group A),diabetic control (group B) and diabetic with Tangmaikang (group C).Blood glucose,blood lipid,HbAlC,kidney to body weight ratio and urinary protein excretion were measured after 12 weeks.Malonyldialdehyde (MDA)level,superoxide dismutase (SOD) activity,glutathione peroxidase (GSH-Px) activity,total sulfhydryl group and protein carbonyl levels in renal tissue were also determined.ResultsCompared to group A,kidney to body weight ratio,urinary protein excretion,MDA,and protein carbonyl levels in group B were significantly higher,while SOD and GSH-Px activities and total sulfhydryl group level were significantly lower than those in group A.Kidney to body weight ratio,urinary protein excretion,MDA,and protein carbonyl level in group C were significantly lower than those in group B.SOD and GSH-Px activity in group C were higher than those in group B.ConclusionTangmaikang can prevent renal hypertrophy and decrease urinary protein excretion in diabetic rats.The renoprotective effects of this drug may be related to his ability to inhibit oxidative and carbonyl stress.

Objective To investigate the effects of epalrestat on oxidative and carbonyl stress in streptozocin-induced diabetic rat kidneys, and to also explore their reno -protecting mechanisms in diabetic rats.Methods Rats were randomly divided into three sub-groups:normal control (group A),diabetic con-trol (group B) and diabetic with epalrestat (group C). Blood glucose, blood lipid, HbA1C, kidney to body weight ratio and urinary protein excretion were measured after 12 weeks.Malonyldialdehyde (MDA) level, superoxide dismutase(SOD) activity, glutathione peroxidase (GSH-Px) activity, total sulfhydryl group and protein carbonyl levels in renal tissue were also determined .Results Compared to group A , kidney to body weight ratio , urinary protein excretion , MDA, and protein carbonyl levels in group B were significantly higher , while SOD and GSH-Px activities and total sulfhydryl group level were significantly lower than those in group A.Kidney to body weight ratio , urinary protein excretion , MDA, and protein carbonyl level in group C were significantly lower than those in group B .SOD and GSH-Px activity in group C were higher than those in group B .Conclusion Epalrestat can prevent renal hypertrophy and decrease urinary protein excretion in diabetic rats .The renoprotective effects of this drug may be related to his ability to inhibit oxi-dative and carbonyl stress .

Objective To evaluate whether sofosbuvir (SOF)-based direct-acting antiviral agents (DAAs) combined with ribavirin (RBV) (combined RBV) can yield benefits to the recipients infected with hepatitis C virus (HCV) genotype 1 (GT1) after liver transplantation through systematic evaluation and Meta-analysis. Methods Multiple databases at home and abroad were systematically searched, the literature screening was conducted according to relevant standards, the quality of literatures was evaluated and data extraction was performed. The literature was divided into two groups according to the recipients with HCV-GT1 hepatitis after liver transplantation who received the treatment combined RBV or SOF-based DAAs alone without RBV (not combined RBV). Meta-analysis of the data was carried out using Rev Man 5.3 and R3.4.3 software. The incidence of sustained virological response 12 weeks (SVR12) after therapy was evaluated. Results A total of 2 195 articles were retrieved, and 6 articles published in English were eventually included according to the inclusion criteria. The Meta-analysis results demonstrated that the incidence of SVR12 did not significantly differ between the combined RBV and not combined RBV groups (P=0.28). However, the incidence of anemia in the combined RBV group was significantly higher than that in the other group (P < 0.01). Both combined RBV and not combined RBV therapies were efficacious in treating HCV-GT1a and HCV-GT1b subtypes after liver transplantation with similar clinical efficacy (P=0.33). The incidence of SVR in HCV-GT1 recipients did not significantly differ after receiving 12- and 24-weeks therapy after liver transplantation (P=0.95). Conclusions When SOF-based DAAs regimen is adopted to treat HCV-GT1 in recipients after liver transplantation, combination with RBV not only fails to improve the virus clearance rate and bring clinical benefits, but also increases the risk of anemia in the recipients.

Primary liver cancer is one of the most malignant tumor in the worldwide.5 years recurrence rate of patients in the early phase is exceeding 70％.Recurrence of HCC is one of the vital factors leading to adverse outcomes.Researchers found that characteristics of tumors,such as tumor size,differentiation and vascular invasion;operation aspect,such as surgical margin width,surgical approach,intraoperative bleeding and transfusion;patient-self and liver transplantation related factors,such as liver disease,donor's age,hepatitis B virus infection of recipient can affect the postoperative recurrence of hepatocellular carcinoma.We summarized the influence factors of postoperative recurrence of HCC via literature review.

Postoperative complications of ERCP include pancreatitis,cholangitis,hemorrhage,mechanical damage (such as perforation) of the digestive tract and drug reaction.Since the the complications definition,surgical indications,operation technique,data collection and processing method were inconsistent,there were controversies for the incidences of complications after ERCP and its risk factors for different institutions.This paper discussed the evolution of ERCP risk factors,current situation and prophylaxis of major complications after ERCP and summarized the current research progress in order to provide theoretical help for prevention and prophylaxis of postoperative complications of ERCP.